Literature DB >> 27150484

Inflammatory Inhibitory Activity of Sesquiterpenoids from Atractylodes macrocephala Rhizomes.

Le Son Hoang1, Manh Hung Tran, Joo-Sang Lee, Quynh Mai Thi Ngo, Mi Hee Woo, Byung Sun Min.   

Abstract

Three new sesquiterpenoids, 13-hydroxyl-atractylenolide II (1), 4-ketone-atractylenolide III (2), and eudesm-4(15)-ene-7β,11-diol (3), along with eleven known compounds (4-14), were isolated from the rhizomes of Atractylodes macrocephala. The structures and relative configurations of 1-3 were determined by analysis of the spectroscopic data, and the absolute configurations of 1 and 2 were assigned by circular dichroism technique. The anti-inflammatory activities of these isolates were evaluated against lipopolysaccharide-induced nitric oxide production in macrophage RAW264.7 cells; compounds 4, 7, and 8 exhibited moderate efficacy with IC50 values of 48.6±0.5, 46.4±3.2, and 32.3±2.9 µM, respectively.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27150484     DOI: 10.1248/cpb.c15-00805

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  15 in total

1.  Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4.

Authors:  Ying Gao; Jundong Wang; Maoyuan Zhao; Ting Xia; Qingsong Liu; Nianzhi Chen; Wenhao Liao; Zhongzhen Zeng; Fengming You; Jinhao Zeng
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

2.  Atractylenolide II Inhibits Proliferation, Motility and Induces Apoptosis in Human Gastric Carcinoma Cell Lines HGC-27 and AGS.

Authors:  Shuang Tian; Hongdan Yu
Journal:  Molecules       Date:  2017-11-03       Impact factor: 4.411

3.  System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia.

Authors:  Chun Wang; Qing Ren; Xue-Tong Chen; Zhi-Qian Song; Zhang-Chi Ning; Jia-He Gan; Xin-Ling Ma; Dong-Rui Liang; Dao-Gang Guan; Zhen-Li Liu; Ai-Ping Lu
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

4.  Antitumor, Antiviral, and Anti-Inflammatory Efficacy of Essential Oils from Atractylodes macrocephala Koidz. Produced with Different Processing Methods.

Authors:  Sihao Gu; Ling Li; Hai Huang; Bing Wang; Tong Zhang
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

Review 5.  A Systematic Review of the Anti-Inflammatory and Immunomodulatory Properties of 16 Essential Oils of Herbs.

Authors:  Xu Zuo; Yinuo Gu; Chao Wang; Jinrong Zhang; Jing Zhang; Guoqiang Wang; Fang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-07       Impact factor: 2.629

6.  Newly Generated Atractylon Derivatives in Processed Rhizomes of Atractylodes macrocephala Koidz.

Authors:  Chunmei Zhai; Jianping Zhao; Amar G Chittiboyina; Yonghai Meng; Mei Wang; Ikhlas A Khan
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411

7.  A Strategy for Screening the Lipid-Lowering Components in Alismatis Rhizoma Decoction Based on Spectrum-Effect Analysis.

Authors:  Xiao-Yan Chang; Jia-Shuo Wu; Fang-Qing Zhang; Zhuang-Zhuang Li; Wei-Yi Jin; Jing-Xun Wang; Wei-Hua Wang; Yue Shi
Journal:  J Anal Methods Chem       Date:  2022-01-04       Impact factor: 2.193

8.  Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.

Authors:  Xuan Xia; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie C Xue; Qingchun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

9.  Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro.

Authors:  Ka Woon Karen Chan; Hau Yin Chung; Wing Shing Ho
Journal:  Molecules       Date:  2020-01-04       Impact factor: 4.411

10.  Bioactive Diterpenes, Norditerpenes, and Sesquiterpenes from a Formosan Soft Coral Cespitularia sp.

Authors:  You-Cheng Lin; Chi-Chien Lin; Yi-Chia Chu; Chung-Wei Fu; Jyh-Horng Sheu
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.